| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64406-029-01 | 64406-029 | HUMAN PRESCRIPTION DRUG | ZURZUVAE | zuranolone | CAPSULE | ORAL | 20231031 | N/A | NDA | NDA217369 | Biogen MA Inc. | ZURANOLONE | 20 mg/1 | 1 BOTTLE in 1 CARTON (64406-029-01) / 14 CAPSULE in 1 BOTTLE |
| 64406-030-01 | 64406-030 | HUMAN PRESCRIPTION DRUG | ZURZUVAE | zuranolone | CAPSULE | ORAL | 20231031 | N/A | NDA | NDA217369 | Biogen MA Inc. | ZURANOLONE | 25 mg/1 | 1 BOTTLE in 1 CARTON (64406-030-01) / 14 CAPSULE in 1 BOTTLE |
| 64406-030-02 | 64406-030 | HUMAN PRESCRIPTION DRUG | ZURZUVAE | zuranolone | CAPSULE | ORAL | 20231031 | N/A | NDA | NDA217369 | Biogen MA Inc. | ZURANOLONE | 25 mg/1 | 1 CARTON in 1 CARTON (64406-030-02) / 1 BLISTER PACK in 1 CARTON / 28 CAPSULE in 1 BLISTER PACK |
| 64406-031-01 | 64406-031 | HUMAN PRESCRIPTION DRUG | ZURZUVAE | zuranolone | CAPSULE | ORAL | 20231031 | N/A | NDA | NDA217369 | Biogen MA Inc. | ZURANOLONE | 30 mg/1 | 1 BOTTLE in 1 CARTON (64406-031-01) / 14 CAPSULE in 1 BOTTLE |